Sfoglia per Autore
Comparison of preclinical dosimetric studies of 177Lu-scFvD2B, 177Lu-PSMA-617 and 177Lu-iPSMA.
2022 Meléndez-Alafort, Laura; Ferro-Flores, Guillermina; Ocampo-Garcia, Blanca; Santos-Cuevas, Clara; Carpanese, Debora; Fracasso, Giulio; Bolzati, Cristina; Rosato, Antonio; DE NARDO, Laura
A 67/64Cu-mixture as a therapeutic alternative to pure 67Cu
2022 De Nardo, L; Pupillo, G; Mou, L; Esposito, J; Rosato, A; Meléndez-Alafort, L
natCr(p,x) or natV(α,x)? Dosimetric assessments at comparison for high-purity 52gMn PET tracer production.
2022 Barbaro, F; Canton, L; Carante, M P; Colombi, A; De Nardo, L; Fontana, A; Meléndez-Alafort, L
Comparison of dosimetric results obtained with different software for the cyclotron produced 47 Sc labeling a DOTA folate radiopharmaceutical
2022 De Dominicis, L.; Nardo, De; Meléndez Alafort, L.; Pupillo, G.; Mou, L.
A feasibility study of the Therapeutic Application of a Mixture of 67/64Cu Radioisotopes produced by cyclotrons with proton irradiation
2022 DE NARDO, Laura; Pupillo, Gaia; Mou, Liliana; Esposito, Juan; Rosato, Antonio; Meléndez-Alafort, Laura
Ac-225-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins
2022 Hernández-Jiménez, Tania; Ferro-Flores, Guillermina; Morales-Ávila, Enrique; Isaac-Olivé, Keila; Ocampo-García, Blanca; Aranda-Lara, Liliana; Santos-Cuevas, Clara; Luna-Gutiérrez, Myrna; De Nardo, Laura; Rosato, Antonio; Meléndez-Alafort, Laura
Therapeutic application of a mixture of 64/67Cu radioisotopes
2021 Barbaro, F.; DE NARDO, Laura; Meléndez-Alafort, Laura; Canton, L.; Carante, M. P.; Colombi, A.; Fontana, A.
Assessment of surviving fraction of prostate cancer cells after a treatment with 64/67CuCl2
2021 Meléndez-Alafort, L.; Pupillo, G.; Mou, L.; Esposito, J.; Rosato, A.; De Nardo, L.
Therapeutic Application of a Mixture of 64/67Cu Radioisotopes.
2021 De Nardo, L.; Pupillo, G.; Mou, L.; Esposito, J.; Rosato, A.; Meléndez-Alafort, L.
52gMn production route for multi-modal imaging applications
2021 Barbaro, F.; DE NARDO, Laura; Meléndez-Alafort, Laura; Canton, L.; Carante, M. P.; Colombi, A.; Fontana, A.
Preliminary dosimetric analysis of DOTA-folate radiopharmaceutical radiolabelled with 47Sc produced through natV(p,x)47Sc cyclotron irradiation
2021 De Nardo, Laura; Pupillo, Gaia; Mou, Liliana; Furlanetto, Davide; Rosato, Antonio; Esposito, Juan; Meléndez-Alafort, Laura
Il progetto REMIX: Research on Emerging Medical radIonuclides from the X-sections
2021 Pupillo, G.; Barbaro, F.; Campostrini, M.; Canton, L.; Carante, M. P.; Cazzola, E.; Cisternino, S.; Colombi, A.; DE DOMINICIS, Lucia; DE NARDO, Laura; Esposito, J.; Fontana, A.; Groppi, F.; Manenti, S.; Petra, Martini; Meléndez-Alafort, Laura; Mou, L.; Rigato, V.; Sciacca, G.
Advancements of 52gMn Production for Multi-Modal Imaging: Comparison of Production Routes with Natural Chromium and Vanadium Targets
2021 Barbaro, F.; DE NARDO, Laura; Meléndez-Alafort, L.; Canton, L.; Carante, M. P.; Colombi, A.; Fontana, A.
Preclinical dosimetric studies of 177Lu-scFvD2B and comparison with 177Lu-PSMA-617 and 177Lu-iPSMA endoradiotherapeutic agents
2021 Melendez-Alafort, L.; Ferro-Flores, G.; Santos-Cuevas, C.; Ocampo-Garcia, B.; Turato, S.; Fracasso, G.; Bolzati, C.; Rosato, A.; De Nardo, L.
Synthesis a new radiopharmaceutical for prostate cancer SPECT imaging
2020 Turato, S; Ferro-Flores, G; Ocampo-Garcia, B; Marzano, C; Carpanese, D; Ferraglia, R; De Nardo, L; Fracasso, G; Bolzati, C; Rosato, A; Meléndez-Alafort, L
[99mTc(N)(DASD)(PNPn)]+ Compounds as Myocardial Perfusion Imaging Agents.
2020 Bolzati, C; Melendez-Alafort, L; Carpanese, D; De Nardo, L; Gandin, V; Marzano, C; Salvarese, N
Conjugation and characterization of a new prostate cancer theranostic radiopharmaceutical
2020 Meléndez-Alafort, L; Carpanese, D; Ferro-Flores, G; Ocampo-Garcia, B; Santos-Cuevas, C; Fracasso, G; De Nardo, L; Bolzati, C; Rosato, A
Analysis of the Dosimetric Contribution of Radionuclides Coproduced through natV(p,x)47Sc Cyclotron Irradiation
2020 DE NARDO, Laura; Furlanetto, Davide; Pupillo, G.; Mou, L.; Esposito, J.; Meléndez-Alafort, L.
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen
2020 Carpanese, D.; Ferro-Flores, G.; Ocampo-Garcia, B.; Santos-Cuevas, C.; Salvarese, N.; Figini, M.; Fracasso, G.; De Nardo, L.; Bolzati, C.; Rosato, A.; Melendez-Alafort, L.
Dosimetry of 51MnCl2 and 52MnCl2 for PET application
2020 De Nardo, L.; Ferro-Flores, G.; Bolzati, C.; Esposito, J.; Meléndez-Alafort, L.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile